These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 12745416)

  • 21. Double-blind study of lofexidine and clonidine in the detoxification of opiate addicts in hospital.
    Kahn A; Mumford JP; Rogers GA; Beckford H
    Drug Alcohol Depend; 1997 Jan; 44(1):57-61. PubMed ID: 9031821
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness of interventions on opiate withdrawal treatment: an overview of systematic reviews.
    Amato L; Davoli M; Ferri M; Gowing L; Perucci CA
    Drug Alcohol Depend; 2004 Mar; 73(3):219-26. PubMed ID: 15036544
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent advances in opiate detoxification: clonidine and lofexidine.
    Washton AM; Resnick RB
    NIDA Res Monogr; 1983 Apr; 43():44-50. PubMed ID: 6410276
    [No Abstract]   [Full Text] [Related]  

  • 24. Psychiatric indications for clonidine: the neuropharmacologic and clinical basis.
    Bond WS
    J Clin Psychopharmacol; 1986 Apr; 6(2):81-7. PubMed ID: 3517082
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effectiveness of combined naloxone/lofexidine in opiate detoxification: results from a double-blind randomized and placebo-controlled trial.
    Beswick T; Best D; Bearn J; Gossop M; Rees S; Strang J
    Am J Addict; 2003; 12(4):295-305. PubMed ID: 14504022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acetyl-L-carnitine in the management of pain during methadone withdrawal syndrome.
    Janiri L; Martinotti G; Tonioni F; Ghelardini C; Nicolai R; Galeotti N; Mosconi L; Calvani M; Bartolini A; Iannoni E
    Clin Neuropharmacol; 2009; 32(1):35-40. PubMed ID: 18978503
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Two new rating scales for opiate withdrawal.
    Handelsman L; Cochrane KJ; Aronson MJ; Ness R; Rubinstein KJ; Kanof PD
    Am J Drug Alcohol Abuse; 1987; 13(3):293-308. PubMed ID: 3687892
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clonidine in opiate withdrawal: review and appraisal of clinical findings.
    Washton AM; Resnick RB
    Pharmacotherapy; 1981; 1(2):140-6. PubMed ID: 6765486
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomised double-blind comparison of lofexidine and clonidine in the out-patient treatment of opiate withdrawal.
    Carnwath T; Hardman J
    Drug Alcohol Depend; 1998 May; 50(3):251-4. PubMed ID: 9649979
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clonidine treatment of the opiate withdrawal syndrome. A review of clinical trials of a theory.
    Agren H
    Acta Psychiatr Scand Suppl; 1986; 327():91-113. PubMed ID: 3529831
    [No Abstract]   [Full Text] [Related]  

  • 31. Management of opioid withdrawal symptoms.
    Med Lett Drugs Ther; 2018 Aug; 60(1554):137-141. PubMed ID: 30133420
    [No Abstract]   [Full Text] [Related]  

  • 32. Prescribing to drug misusers in practice--often effective, but rarely straightforward.
    Seivewright N; Iqbal MZ
    Addict Biol; 2002 Jul; 7(3):269-77. PubMed ID: 12126485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Opioid dependence.
    Praveen KT; Law F; O'Shea J; Melichar J
    Am Fam Physician; 2012 Sep; 86(6):565-6. PubMed ID: 23062049
    [No Abstract]   [Full Text] [Related]  

  • 34. Expanded table: Some drugs for management of opioid withdrawal symptoms.
    Med Lett Drugs Ther; 2018 Aug; 60(1554):e144-e146. PubMed ID: 30133422
    [No Abstract]   [Full Text] [Related]  

  • 35. [Detoxification in withdrawal state in methadone maintenance patients].
    Sivolap I; Savchenkov VA; Aksel'rod BA; Kubarev DA; Chichenkov TO
    Zh Nevrol Psikhiatr Im S S Korsakova; 2003; 103(11):33-7. PubMed ID: 14681963
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pupillometric changes during gradual opiate detoxification correlate with changes in symptoms of opiate withdrawal as measured by the Weak Opiate Withdrawal Scale.
    Rosse RB; Johri S; Goel M; Rahman F; Jawor KA; Deutsch SI
    Clin Neuropharmacol; 1998; 21(5):312-5. PubMed ID: 9789712
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alpha2 adrenergic agonists for the management of opioid withdrawal.
    Gowing L; Farrell M; Ali R; White J
    Cochrane Database Syst Rev; 2001; (1):CD002024. PubMed ID: 11279747
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Double-blind randomised controlled trial of lofexidine versus clonidine in the treatment of heroin withdrawal.
    Lin SK; Strang J; Su LW; Tsai CJ; Hu WH
    Drug Alcohol Depend; 1997 Nov; 48(2):127-33. PubMed ID: 9363412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alpha2 adrenergic agonists for the management of opioid withdrawal.
    Gowing L; Farrell M; Ali R; White J
    Cochrane Database Syst Rev; 2004 Oct; (4):CD002024. PubMed ID: 15495025
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the effects of lofexidine and clonidine on naloxone-precipitated withdrawal in opioid-dependent humans.
    Walsh SL; Strain EC; Bigelow GE
    Addiction; 2003 Apr; 98(4):427-39. PubMed ID: 12653813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.